Colson PH, Virsolvy A, Gaudard P et al (2016) Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: implications for its safety profile
PMID: 34626851 Dungan K, DeSantis A (2016): Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes mellitus
rxlist.com Austedo Keywords Valbenazine Trade Name: Ingrezza Drug Class: Rx of Tardive dyskinesia (monoamine depletor) Mechanism of Action: a selective competitive inhibitor of VMAT2, similar to tetrabenazine the monoamine vesicular monoamine uptake transporter (VMAT2) transports (loads) cytoplasmic monoamine neurotransmitters (dopamine, norepinephrine, histamine, serotonin) into presynaptic storage vesicles found in sympathetic nerve terminals
Gastric acid helps keep those cations in soluble form
Reduce dose by 33% every 3 days over a 9-day taper window, then discontinue entirely
Yamany et al, 2019